473 related articles for article (PubMed ID: 25258533)
1. Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.
Shi L; Palacio-Mancheno P; Badami J; Shin DW; Zeng M; Cardoso L; Tu R; Fu BM
Int J Nanomedicine; 2014; 9():4437-48. PubMed ID: 25258533
[TBL] [Abstract][Full Text] [Related]
2. Quantification of blood-brain barrier solute permeability and brain transport by multiphoton microscopy.
Shi L; Zeng M; Sun Y; Fu BM
J Biomech Eng; 2014 Mar; 136(3):031005. PubMed ID: 24193698
[TBL] [Abstract][Full Text] [Related]
3. Temporal effects of vascular endothelial growth factor and 3,5-cyclic monophosphate on blood-brain barrier solute permeability in vivo.
Shi L; Zeng M; Fu BM
J Neurosci Res; 2014 Dec; 92(12):1678-89. PubMed ID: 25066133
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments.
Poon C; Pellow C; Hynynen K
Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773
[No Abstract] [Full Text] [Related]
5. Contrast-enhanced ultrasound imaging for the detection of focused ultrasound-induced blood-brain barrier opening.
Fan CH; Lin WH; Ting CY; Chai WY; Yen TC; Liu HL; Yeh CK
Theranostics; 2014; 4(10):1014-25. PubMed ID: 25161701
[TBL] [Abstract][Full Text] [Related]
6. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
7. Investigating the effects of dexamethasone on blood-brain barrier permeability and inflammatory response following focused ultrasound and microbubble exposure.
McMahon D; Oakden W; Hynynen K
Theranostics; 2020; 10(4):1604-1618. PubMed ID: 32042325
[No Abstract] [Full Text] [Related]
8. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound.
Yang FY; Lee PY
Int J Nanomedicine; 2012; 7():2573-82. PubMed ID: 22679368
[TBL] [Abstract][Full Text] [Related]
10. Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease.
Lynch M; Heinen S; Markham-Coultes K; O'Reilly M; Van Slyke P; Dumont DJ; Hynynen K; Aubert I
Int J Med Sci; 2021; 18(2):482-493. PubMed ID: 33390817
[TBL] [Abstract][Full Text] [Related]
11. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain.
Jung B; Huh H; Lee EH; Han M; Park J
J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
[TBL] [Abstract][Full Text] [Related]
13. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors.
Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL
J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759
[TBL] [Abstract][Full Text] [Related]
14. Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model.
Arsiwala TA; Sprowls SA; Blethen KE; Fladeland RA; Wolford CP; Kielkowski BN; Glass MJ; Wang P; Wilson O; Carpenter JS; Ranjan M; Finomore V; Rezai A; Lockman PR
Fluids Barriers CNS; 2022 Sep; 19(1):72. PubMed ID: 36076213
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound enhanced delivery of macromolecular agents in brain tumor rat model.
Yang FY; Horng SC
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5573-6. PubMed ID: 22255602
[TBL] [Abstract][Full Text] [Related]
16. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Different Microbubbles in Assisting Focused Ultrasound-Induced Blood-Brain Barrier Opening.
Wu SK; Chu PC; Chai WY; Kang ST; Tsai CH; Fan CH; Yeh CK; Liu HL
Sci Rep; 2017 Apr; 7():46689. PubMed ID: 28425493
[TBL] [Abstract][Full Text] [Related]
18. Focused Ultrasound and Microbubble Treatment Increases Delivery of Transferrin Receptor-Targeting Liposomes to the Brain.
Olsman M; Sereti V; Mühlenpfordt M; Johnsen KB; Andresen TL; Urquhart AJ; Davies CL
Ultrasound Med Biol; 2021 May; 47(5):1343-1355. PubMed ID: 33608142
[TBL] [Abstract][Full Text] [Related]
19. Influence of focused ultrasound on locoregional drug delivery to the brain: Potential implications for brain tumor therapy.
Uribe Cardenas R; Laramee M; Ray I; Dahmane N; Souweidane M; Martin B
J Control Release; 2023 Oct; 362():755-763. PubMed ID: 37659767
[TBL] [Abstract][Full Text] [Related]
20. Acute Inflammatory Response Following Increased Blood-Brain Barrier Permeability Induced by Focused Ultrasound is Dependent on Microbubble Dose.
McMahon D; Hynynen K
Theranostics; 2017; 7(16):3989-4000. PubMed ID: 29109793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
